LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 2 of 166
Next
>>
>
26 to 50 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	WZ-4-145	0.04	uM	LJP6	72	hr	1097	2843	3769	0.7544	0.6535
BT-20	XMD16-144	0.04	uM	LJP5	72	hr	1097	2663	3769	0.7066	0.5862
BT-20	Brivanib	0.04	uM	LJP5	72	hr	1097	3576	3769	0.9487	0.9276
BT-20	Buparlisib	0.04	uM	LJP5	72	hr	1097	3777	3769	1.0021	1.0029
BT-20	BX-912	0.04	uM	LJP5	72	hr	1097	3479	3769	0.9229	0.8913
BT-20	Canertinib	0.04	uM	LJP6	72	hr	1097	3493	3769	0.9268	0.8968
BT-20	Celastrol	0.04	uM	LJP6	72	hr	1097	3972	3769	1.0539	1.0760
BT-20	CGP60474	0.04	uM	LJP5	72	hr	1097	3053	3769	0.8101	0.7321
BT-20	CGP60474	0.04	uM	LJP6	72	hr	1097	724	3769	0.1921	-0.1397
BT-20	CHIR-99021	0.04	uM	LJP6	72	hr	1097	3192	3769	0.8469	0.7840
BT-20	CP724714	0.04	uM	LJP5	72	hr	1097	3635	3769	0.9644	0.9498
BT-20	CP466722	0.04	uM	LJP5	72	hr	1097	4112	3769	1.0910	1.1284
BT-20	Crizotinib	0.04	uM	LJP5	72	hr	1097	3340	3769	0.8861	0.8393
BT-20	Momelotinib	0.04	uM	LJP5	72	hr	1097	3659	3769	0.9708	0.9588
BT-20	Dasatinib	0.04	uM	LJP5	72	hr	1097	3075	3769	0.8159	0.7403
BT-20	Dasatinib	0.04	uM	LJP6	72	hr	1097	1604	3769	0.4256	0.1898
BT-20	Dovitinib	0.04	uM	LJP5	72	hr	1097	3447	3769	0.9145	0.8794
BT-20	Enzastaurin	0.04	uM	LJP5	72	hr	1097	3937	3769	1.0446	1.0629
BT-20	Erlotinib	0.04	uM	LJP5	72	hr	1097	3377	3769	0.8960	0.8532
BT-20	Foretinib	0.04	uM	LJP5	72	hr	1097	4073	3769	1.0807	1.1138
BT-20	R406	0.04	uM	LJP6	72	hr	1097	3449	3769	0.9151	0.8802
BT-20	Pictilisib	0.04	uM	LJP6	72	hr	1097	2743	3769	0.7278	0.6160
BT-20	Gefitinib	0.04	uM	LJP6	72	hr	1097	3523	3769	0.9346	0.9077
BT-20	Geldanamycin	0.04	uM	LJP5	72	hr	1097	1707	3769	0.4529	0.2283
BT-20	Geldanamycin	0.04	uM	LJP6	72	hr	1097	1280	3769	0.3396	0.0684

|<
<<
Previous
Page 2 of 166
Next
>>
>
26 to 50 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)